Modified forms of low density lipoprotein and atherosclerosis

Area of Science:

• Biochemistry
• Cardiovascular Biology
• Pathology

Background:

• Modified low-density lipoprotein (LDL) is linked to increased atherosclerosis.
• Modified LDL exhibits enhanced uptake by macrophages, leading to foam cell formation.
• Modified LDL also stimulates cytokine and growth factor secretion from arterial wall cells.

Purpose of the Study:

• To investigate the impact of various LDL modifications on atherogenicity.
• To understand the mechanisms underlying modified LDL's role in atherosclerosis.
• To explore the potential of inhibiting LDL modifications to prevent atherosclerotic lesion progression.

Main Methods:

• Examined non-enzymatic (proteoglycans, glycosylation, immune complexes) and enzymatic (lipases, oxygenases) LDL modifications.
• Assessed changes in physicochemical properties (size, charge) and biological functions (cellular uptake, secretion).
• Focused on oxidative modification of LDL, including its in vivo occurrence and mechanism involving lipid peroxidation and macrophage receptors.

Main Results:

• Non-enzymatic and enzymatic modifications alter LDL's physicochemical and biological properties.
• Oxidative modification of LDL occurs in vivo, involving lipid peroxidation and macrophage receptor binding.
• Certain LDL modifications increase susceptibility to further alterations like lipid modification, aggregation, and oxidation.
• Multiple modified LDL forms may coexist in vivo during atherogenesis.

Conclusions:

• Modified LDL plays a significant role in the pathogenesis of atherosclerosis.
• Understanding LDL modification pathways is crucial for developing therapeutic strategies.
• Inhibiting LDL modifications presents a potential therapeutic target to arrest atherosclerotic lesion development.